Pharsight

UCB PHARMA SA PATENTS FACING OPPOSITIONS

Top patents of UCB PHARMA SA facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP2345668B1 22 Sep, 2021 Sclerostin Epitopes Apr, 2026 1